Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

about

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q35668187

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Use of Valacyclovir for the tr ...... tic stem cell transplantation.

@ast

Use of Valacyclovir for the tr ...... tic stem cell transplantation.

@en

type

Item

label

Use of Valacyclovir for the tr ...... tic stem cell transplantation.

@ast

Use of Valacyclovir for the tr ...... tic stem cell transplantation.

@en

prefLabel

Use of Valacyclovir for the tr ...... tic stem cell transplantation.

@ast

Use of Valacyclovir for the tr ...... tic stem cell transplantation.

@en

P1476

Use of Valacyclovir for the tr ...... etic stem cell transplantation

@en

P2093

Aloysius Yew-Leng Ho

http://www.w3.org/2001/XMLSchema#string

Colin Phipps Diong

http://www.w3.org/2001/XMLSchema#string

Ha-Thi-Thu Truong

http://www.w3.org/2001/XMLSchema#string

Shin-Yeu Ong

http://www.w3.org/2001/XMLSchema#string

Yeh-Ching Linn

http://www.w3.org/2001/XMLSchema#string

Yeow-Tee Goh

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions of cytomegalovirus infection and disease in transplant recipients

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.

Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.

Investigation of CMV disease in immunocompromised patients

Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma

Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.

Impact of ethnicity on human umbilical cord blood banking: a systematic review.

The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.

Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.

P2888

s12878-015-0028-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12878-015-0028-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Ying Khee Hwang

P577

2015-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278788505

http://www.w3.org/2001/XMLSchema#string

P6179

1035877246

http://www.w3.org/2001/XMLSchema#string

P698

26090121

http://www.w3.org/2001/XMLSchema#string

P921

valacyclovir

P932

4471913

http://www.w3.org/2001/XMLSchema#string